ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 104,97
0,16%
Dow Jones
39 671,04
-0,51%
DAX
18 726,21
0,24%
Brent Oil
82,335
0,99%
Bitcoin
69 720,48
0,89%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Repligen Corp (RGEN)

  7. Repligen Corp (RGEN) Actualités

RGEN

Repligen (RGEN)

Repligen Corp
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RGEN
DateHeureSourceTitreSymboleSociété
22/05/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
22/05/202413h30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming June Investor ConferencesNASDAQ:RGENRepligen Corp
21/05/202422h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
17/05/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
07/05/202413h30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming May Investor ConferencesNASDAQ:RGENRepligen Corp
01/05/202413h30GlobeNewswire Inc.Repligen Reports First Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
17/04/202413h30GlobeNewswire Inc.Repligen to Report First Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
19/03/202412h30GlobeNewswire Inc.Repligen Appoints Maggie A. Pax to Board of DirectorsNASDAQ:RGENRepligen Corp
22/02/202422h26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RGENRepligen Corp
21/02/202413h30GlobeNewswire Inc.Repligen Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RGENRepligen Corp
07/02/202413h30GlobeNewswire Inc.Repligen to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RGENRepligen Corp
06/02/202419h41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RGENRepligen Corp
19/12/202313h30GlobeNewswire Inc.Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RGENRepligen Corp
16/12/202301h04Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RGENRepligen Corp
07/12/202313h30GlobeNewswire Inc.Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription AgreementsNASDAQ:RGENRepligen Corp
14/11/202320h01GlobeNewswire Inc.UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability ReportNASDAQ:RGENRepligen Corp
14/11/202313h30GlobeNewswire Inc.Repligen Announces Publication of the Company’s 2022 Sustainability ReportNASDAQ:RGENRepligen Corp
07/11/202313h30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming Investor ConferencesNASDAQ:RGENRepligen Corp
02/11/202312h30GlobeNewswire Inc.Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF DeviceNASDAQ:RGENRepligen Corp
31/10/202321h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RGENRepligen Corp
31/10/202312h30GlobeNewswire Inc.Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceNASDAQ:RGENRepligen Corp
17/10/202313h30GlobeNewswire Inc.Repligen to Report Third Quarter 2023 Financial ResultsNASDAQ:RGENRepligen Corp
04/10/202302h03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
02/10/202313h30GlobeNewswire Inc.Repligen Appoints Olivier Loeillot as President and Chief Commercial OfficerNASDAQ:RGENRepligen Corp
26/09/202313h30GlobeNewswire Inc.Repligen Announces Agreement to Acquire Fluid Management Innovator MetenovaNASDAQ:RGENRepligen Corp
12/09/202313h30GlobeNewswire Inc.Repligen Appoints Jason K. Garland as Chief Financial OfficerNASDAQ:RGENRepligen Corp
01/09/202313h30GlobeNewswire Inc.Repligen Corporation to Present at Wells Fargo Healthcare ConferenceNASDAQ:RGENRepligen Corp
17/08/202314h00GlobeNewswire Inc.Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process IntensificationNASDAQ:RGENRepligen Corp
02/08/202313h30GlobeNewswire Inc.Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceNASDAQ:RGENRepligen Corp
19/07/202313h30GlobeNewswire Inc.Repligen to Report Second Quarter 2023 Financial ResultsNASDAQ:RGENRepligen Corp
 Showing the most relevant articles for your search:NASDAQ:RGEN

Dernières Valeurs Consultées

BIT
F11467
Vontobel Financial Produ...
EU
ALTPC
SMTPC Societe Marseillai...
NYSE
ACHR
Archer Aviation
UNSW3
UCOETH
UnirisToken
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés